Scharp Technologies, its research scientists, and extended network of scientists, clinicians, and health professionals, are leaders in science and technology, pioneering a better approach to health and aging.
Scharp Labs and RESCUE conduct ongoing research into how to best support cells to further understand how they function at peak performance. That research helps us to offer the best in class clinically tested products to RESCUE customers.
Our work studying the adult human stem cell-derived MDFc19 has shown measurable clinical results in supporting natural dermal fibroblast activity and the resulting acceleration of natural cellular turnover.
The diagram at right shows how properly optimized dermal fibroblasts appear in population in relation to unoptimized fibroblasts.
Slide to compare